Literature DB >> 27408438

Shoulder Myeloid Sarcoma: An Initial Presentation of CML Blast Crisis.

Ankur Jain1, Kamal Kant Sahu1, Saniya Sharma1, Arvind Rajwanshi1, Vikas Suri1, Pankaj Malhotra1.   

Abstract

Myeloid sarcoma (MS) represents extra medullary accumulation of the immature cells of granulocytic series and occurs most commonly in the setting of acute myelogenous leukemia. Its occurrence in chronic myeloid leukemia (CML), myelodysplastic syndrome and other myeloproliferative neoplasm is uncommon. We here in report a 35-year old lady who was diagnosed as CML-chronic phase (CP) in the year 2004 and was on imatinib (400 mg OD) since then with regular follow up and good compliance. She had progression to accelerated phase in April 2014 which was managed by increasing the dose of imatinib to 600 mg OD. In August 2015, she presented with complaints of pain and swelling of the left shoulder suggestive of septic arthritis. Investigations revealed an ill-defined lesion involving muscles around the shoulder and clavicle. Absence of response to antibiotics and negative work up for infectious etiology raised the suspicion for MS which was later confirmed by immunohistochemistry of the aspirate from the lesion. Bone marrow examination was consistent with CML-CP. Hence, the diagnosis of CML with extra medullary blast crises was made. Patient was treated with a combination of high dose imatinib, hydroxyurea, cytarabine and local radiotherapy. Rarity of MS involving the shoulder and it's resemblance to septic arthritis has been highlighted in the present case. We emphasize the importance of immunohistochemistry of the aspirate for the timely and correct diagnosis of the cases who do not respond to an initial antibiotic trial.

Entities:  

Keywords:  Chronic myeloid leukemia; Granulocytic sarcoma; Radiotherapy; Shoulder

Year:  2016        PMID: 27408438      PMCID: PMC4925556          DOI: 10.1007/s12288-016-0656-0

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  4 in total

1.  Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia.

Authors:  Apostolia-Maria Tsimberidou; Hagop M Kantarjian; Sijin Wen; Michael J Keating; Susan O'Brien; Mark Brandt; Sherry Pierce; Emil J Freireich; L Jeffrey Medeiros; Elihu Estey
Journal:  Cancer       Date:  2008-09-15       Impact factor: 6.860

2.  Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy.

Authors:  A-M Tsimberidou; H M Kantarjian; E Estey; J E Cortes; S Verstovsek; S Faderl; D A Thomas; G Garcia-Manero; A Ferrajoli; J T Manning; M J Keating; M Albitar; S O'Brien; F J Giles
Journal:  Leukemia       Date:  2003-06       Impact factor: 11.528

Review 3.  Myeloid Sarcoma: An Unusual Case of Mediastinal Mass and Malignant Pleural Effusion with Review of Literature.

Authors:  Kamal Kant Sahu; Ruchita Tyagi; Arjun Datt Law; Alka Khadwal; Gaurav Prakash; Arvind Rajwanshi; Subhash Chander Varma; Pankaj Malhotra
Journal:  Indian J Hematol Blood Transfus       Date:  2015-04-01       Impact factor: 0.900

4.  Myeloid sarcoma: current approach and therapeutic options.

Authors:  Batia Avni; Maya Koren-Michowitz
Journal:  Ther Adv Hematol       Date:  2011-10
  4 in total
  2 in total

Review 1.  Cardiac Myeloid Sarcoma: Review of Literature.

Authors:  Archana Gautam; Ghazal Kooshk Jalali; Kamal Kant Sahu; Prateek Deo; Sikander Ailawadhi
Journal:  J Clin Diagn Res       Date:  2017-03-01

Review 2.  Shoulder pain: a hematologist's perspective.

Authors:  Ankur Jain; Pankaj Malhotra; Subhash Varma
Journal:  J Orthop Traumatol       Date:  2016-04-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.